Drug-related problems in cardiac children

Nirmeen Sabry1, Samar Farid, Dalia Dawoud

  • 1Department of Clinical Pharmacy, Faculty of Pharmacy Cairo University, Cairo, Egyptes Nonprofit Organization, Milan, Italy - nirmeen.sabry@pharma.cu.edu.eg.

Minerva Pediatrica
|July 19, 2014
PubMed

Insights

Drug-related problems (DRPs) are frequent in pediatric cardiac care, with drug-drug interactions and dosing issues being most common. Clinical pharmacists are vital for identifying and resolving these issues to improve patient outcomes.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Pediatric Cardiology

Background:

  • Drug-related problems (DRPs) are defined as events interfering with desired health outcomes.
  • Pediatric cardiac patients face unique challenges in drug therapy management.
  • Understanding DRPs in this population is crucial for optimizing care.

Purpose of the Study:

  • To determine the frequency and characteristics of DRPs in pediatric patients.
  • To identify common types of DRPs in a tertiary cardiac care setting.
  • To provide evidence for targeted interventions and pharmacist involvement.

Main Methods:

  • Prospective observational cohort study over three months.
  • Inclusion of pediatric patients (0-18 years) in a cardiac care center.
  • Daily review of medical records, medication charts, and lab data by clinical pharmacists.

Main Results:

  • A total of 313 DRPs were identified in 60 pediatric patients (average 5.22 per patient).
  • Most frequent DRPs included drug-drug interactions (45.69%), unnecessary medication (31.95%), and under-dosing (21.09%).
  • Physicians accepted 65% of pharmacist-suggested interventions.

Conclusions:

  • DRPs are highly prevalent in pediatric cardiac care, primarily involving drug interactions and dosing.
  • Targeted prescriber education on drug interactions and dosing is recommended.
  • Increased clinical pharmacist presence on wards is essential for DRP identification and resolution.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K